I read it as approved the resubmission - but I see how it can be read otherwise if not read carefully. And I just saw JBStrikesBack agrees. I guess that's what adults do. Learn from mistakes and move forward.Anything of your comments you care to correct? Was there also ambiguity in your interpretation of "pro-forma"? Is there nuance to your one-sided assessment of this stock? I can list a few other examples if it helps.
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-962
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
96.5¢ |
Change
-0.005(0.52%) |
Mkt cap ! $1.087B | |||
| Open | High | Low | Value | Volume |
| 98.0¢ | 98.5¢ | 95.0¢ | $2.395M | 2.483M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 57659 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 91.5¢ | 13260 | 4 |
View Market Depth
| Last trade - 15.59pm 13/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |